PYXS position history
The shares of Pyxis Oncology (PYXS) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q3: 170,000 shares, $624K, 0.08% of portfolio, New
- 2024 Q4: 1,037,421 shares, $1.6M, 0.25% of portfolio, Add +510.2%
- 2025 Q1: 1,037,421 shares, $1M, 0.19% of portfolio
- 2025 Q2: 1,037,421 shares, $1.1M, 0.24% of portfolio
- 2025 Q3: 1,037,421 shares, $2.3M, 0.43% of portfolio
- 2025 Q4: 1,037,421 shares, $1.2M, 0.17% of portfolio
- 2026 Q1: 1,010,510 shares, $1.5M, 0.23% of portfolio, Reduce −2.6%
- 2026 Q2: 864,277 shares, $2.6M, 0.36% of portfolio, Reduce −14.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|